 The study found that severe cases of COVID-19 are associated with damage to the endothelial glycocalyx, leading to endothelial dysfunction and barrier failure. This damage can be reversed by fucoidin, suggesting that it may be possible to treat this condition early in the course of the disease. This article was authored by Lu Xiaoyun Yuan, Xu Zhencheng, Wendy MPJ Sol and others.